1. Home
  2. AL vs AXSM Comparison

AL vs AXSM Comparison

Compare AL & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AL
  • AXSM
  • Stock Information
  • Founded
  • AL 2010
  • AXSM 2012
  • Country
  • AL United States
  • AXSM United States
  • Employees
  • AL N/A
  • AXSM N/A
  • Industry
  • AL Diversified Commercial Services
  • AXSM Biotechnology: Pharmaceutical Preparations
  • Sector
  • AL Consumer Discretionary
  • AXSM Health Care
  • Exchange
  • AL Nasdaq
  • AXSM Nasdaq
  • Market Cap
  • AL 7.1B
  • AXSM 5.9B
  • IPO Year
  • AL 2011
  • AXSM 2015
  • Fundamental
  • Price
  • AL $63.60
  • AXSM $121.35
  • Analyst Decision
  • AL Buy
  • AXSM Strong Buy
  • Analyst Count
  • AL 5
  • AXSM 19
  • Target Price
  • AL $61.40
  • AXSM $174.26
  • AVG Volume (30 Days)
  • AL 2.3M
  • AXSM 471.2K
  • Earning Date
  • AL 11-03-2025
  • AXSM 11-03-2025
  • Dividend Yield
  • AL 1.38%
  • AXSM N/A
  • EPS Growth
  • AL 76.97
  • AXSM N/A
  • EPS
  • AL 8.24
  • AXSM N/A
  • Revenue
  • AL $2,873,037,000.00
  • AXSM $495,033,000.00
  • Revenue This Year
  • AL $11.13
  • AXSM $63.62
  • Revenue Next Year
  • AL $6.32
  • AXSM $55.72
  • P/E Ratio
  • AL $7.72
  • AXSM N/A
  • Revenue Growth
  • AL 6.15
  • AXSM 69.83
  • 52 Week Low
  • AL $38.25
  • AXSM $75.56
  • 52 Week High
  • AL $64.30
  • AXSM $139.13
  • Technical
  • Relative Strength Index (RSI)
  • AL 64.48
  • AXSM 56.85
  • Support Level
  • AL $63.25
  • AXSM $117.30
  • Resistance Level
  • AL $63.77
  • AXSM $124.13
  • Average True Range (ATR)
  • AL 0.18
  • AXSM 3.25
  • MACD
  • AL -0.19
  • AXSM 0.01
  • Stochastic Oscillator
  • AL 46.00
  • AXSM 64.96

About AL Air Lease Corporation

Air Lease Corp is an aircraft leasing company based in the United States. It is engaged in purchasing commercial jet aircrafts directly from aircraft manufacturers and leasing those aircraft to airlines throughout the world to generate attractive returns on equity. The company also sells aircraft from its fleet to third parties, including other leasing companies, financial services companies, airlines, and other investors, and offers fleet management services to investors and owners of aircraft portfolios for a management fee. Geographically, it derives a majority of its revenue from the Asia-Pacific region and the rest from Europe, Middle East and Africa, Central America, South America, Mexico, the United States, and Canada.

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Share on Social Networks: